Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy
- PMID: 20866115
- DOI: 10.2165/11317620-000000000-00000
Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy
Abstract
Chronic pruritus is a major and distressing symptom of many cutaneous and systemic diseases and can significantly impair the patient's quality of life. Pruritus perception is the final result of a complex network involving dedicated nerve pathways and brain areas, and an increasing number of peripheral and central mediators are thought to be involved. Itch is associated with most cutaneous disorders and, in these circumstances, its management overlaps with that of the skin disease. Itch can also occur without associated skin diseases or primary skin lesions, but only with nonspecific lesions secondary to rubbing or scratching. Chronic itch with no or minimal skin changes can be secondary to important diseases, such as neurologic disorders, chronic renal failure, cholestasis, systemic infections, malignancies, and endocrine disorders, and may also result from exposure to some drugs. The search for the cause of pruritus usually requires a meticulous step-by-step assessment involving careful history taking as well as clinical examination and laboratory investigations. Few evidence-based treatments for pruritus are available. Topical therapy, oral histamine H(1) receptor antagonists, and phototherapy with UV radiation can target pruritus elicitation in the skin, whereas antiepileptic drugs, opioid receptor antagonists, and antidepressants can block signal processing in the CNS.
Similar articles
-
Itch Management in the Elderly.Curr Probl Dermatol. 2016;50:192-201. doi: 10.1159/000446094. Epub 2016 Aug 23. Curr Probl Dermatol. 2016. PMID: 27578088 Review.
-
Diagnosis and Management of Neuropathic Itch.Dermatol Clin. 2018 Jul;36(3):213-224. doi: 10.1016/j.det.2018.02.005. Epub 2018 Apr 26. Dermatol Clin. 2018. PMID: 29929594 Review.
-
Novel agents for intractable itch.Skin Therapy Lett. 2008 Feb;13(1):6-9. Skin Therapy Lett. 2008. PMID: 18357364 Review.
-
End-Stage Renal Disease Chronic Itch and Its Management.Dermatol Clin. 2018 Jul;36(3):277-292. doi: 10.1016/j.det.2018.02.007. Epub 2018 Apr 26. Dermatol Clin. 2018. PMID: 29929599 Review.
-
Prurigo Nodularis Management.Curr Probl Dermatol. 2016;50:94-101. doi: 10.1159/000446049. Epub 2016 Aug 23. Curr Probl Dermatol. 2016. PMID: 27578077 Review.
Cited by
-
[Rehabilitation for patients with chronic pruritus].Dermatologie (Heidelb). 2024 Aug;75(8):617-622. doi: 10.1007/s00105-024-05382-z. Epub 2024 Jun 27. Dermatologie (Heidelb). 2024. PMID: 38935293 Review. German.
-
Adherence to dermatologic treatment: A retrospective cross-sectional study on geriatric patients.North Clin Istanb. 2023 Nov 22;10(6):803-808. doi: 10.14744/nci.2022.20788. eCollection 2023. North Clin Istanb. 2023. PMID: 38328717 Free PMC article.
-
Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System.J Pharm Health Care Sci. 2019 Dec 19;5:27. doi: 10.1186/s40780-019-0156-0. eCollection 2019. J Pharm Health Care Sci. 2019. PMID: 31890238 Free PMC article.
-
Investigating endogenous µ-opioid receptors in human keratinocytes as pharmacological targets using novel fluorescent ligand.PLoS One. 2017 Dec 6;12(12):e0188607. doi: 10.1371/journal.pone.0188607. eCollection 2017. PLoS One. 2017. PMID: 29211767 Free PMC article.
-
Sensory TRP channels contribute differentially to skin inflammation and persistent itch.Nat Commun. 2017 Oct 30;8(1):980. doi: 10.1038/s41467-017-01056-8. Nat Commun. 2017. PMID: 29081531 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
